Increase in the nasopharyngeal carriage of non-vaccine serogroup 15 Streptococcus pneumoniae after introduction of children pneumococcal conjugate vaccination in Hong Kong

Diagnostic Microbiology and Infectious Disease

Volumn 81, Issue 2, 2015, Pages 145-148

  Ho, Pak Leung ^a   Chiu, Susan S ^a   Law, Pierra Y ^a   Chan, Eunice L ^a   Lai, Eileen L ^a   Chow, Kin Hung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Drug resistance; Prevalence; Serotype; Streptococcus pneumoniae

Indexed keywords

CEFOTAXIME; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILD; COHORT ANALYSIS; DIARRHEA; DISEASE DURATION; FEMALE; HONG KONG; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MOLECULAR TYPING; NOSE SMEAR; PNEUMOCOCCAL INFECTION; RESPIRATORY TRACT DISEASE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION; CLASSIFICATION; GENETICS; GENOTYPE; HETEROZYGOTE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; PREVENTION AND CONTROL; UTILIZATION;

CARRIER STATE; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENOTYPE; HONG KONG; HUMANS; INFANT; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROGROUP; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84922333949     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.11.006     Document Type: Article

References (22)

1. Chiba N., Morozumi M., Shouji M., Wajima T., Iwata S., Ubukata K. Changes in capsule and drug resistance of pneumococci after introduction of PCV7, Japan, 2010-2013. Emerg Infect Dis 2014, 20:1132-1139.
2. Chiu S.S., Ho P.L., Chow F.K., Yuen K.Y., Lau Y.L. Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrob Agents Chemother 2001, 45:2765-2770.
3. Clincal and Laboratory Standard Institute Performance standards for antimicrobial susceptibility testing: Twenty-fourth informational supplement M100-S24 2014, Clincal and Laboratory Standard Institute, Wayne, PA.
4. Croucher N.J., Finkelstein J.A., Pelton S.I., Mitchell P.K., Lee G.M., Parkhill J., et al. Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet 2013, 45:656-663.
5. Dagan R. Serotype replacement in perspective. Vaccine 2009, 27(Suppl. 3):C22-C24.
6. Del A.E., Brotons P., Monsonis M., Trivino M., Inigo M., Selva L., et al. High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines. Clin Microbiol Infect 2014, 20:684-689.
7. Enright M.C., Spratt B.G. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998, 144(Pt 11):3049-3060.
8. Ho P.L., Chiu S.S., Cheung C.H., Lee R., Tsai T.F., Lau Y.L. Invasive pneumococcal disease burden in Hong Kong children. Pediatr Infect Dis J 2006, 25:454-455.
9. Ho P.L., Ang I., Chow K.H., Lai E.L., Chiu S.S. The prevalence and characteristics of Streptococcus pneumoniae isolates expressing serotypes 6C and 6D in Hong Kong prior to the introduction of the 7-valent pneumococcal conjugate vaccine. Diagn Microbiol Infect Dis 2010, 68:439-444.
10. Ho P.L., Chiu S.S., Ang I., Lau Y.L. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009. Vaccine 2011, 29:3270-3275.
11. Ho P.L., Chiu S.S., Chan M.Y., Ang I., Chow K.H., Lau Y.L. Changes in nasopharyngeal carriage and serotype distribution of antibiotic-resistant Streptococcus pneumoniae before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong. Diagn Microbiol Infect Dis 2011, 71:327-334.
12. Levy C., Varon E., Picard C., Bechet S., Martinot A., Bonacorsi S., et al. Trends of Pneumococcal meningitis in children after Introduction of the 13-valent pneumococcal conjugate vaccine in France. Pediatr Infect Dis J 2014, 33:1216-1221.
13. Li Y., Tomita H., Lv Y., Liu J., Xue F., Zheng B., et al. Molecular characterization of erm(B)- and mef(E)-mediated erythromycin-resistant Streptococcus pneumoniae in China and complete DNA sequence of Tn2010. J Appl Microbiol 2011, 110:254-265.
14. Martin J.M., Hoberman A., Paradise J.L., Barbadora K.A., Shaikh N., Bhatnagar S., et al. Emergence of Streptococcus pneumoniae Serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr Infect Dis J 2014, 33:e286-e290.
15. Mehr S., Wood N. Streptococcus pneumoniae - a review of carriage, infection, serotype replacement and vaccination. Paediatr Respir Rev 2012, 13:258-264.
16. Miller E., Andrews N.J., Waight P.A., Slack M.P., George R.C. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011, 11:760-768.
17. Moore M.R., Gertz R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008, 197:1016-1027.
18. Pai R., Gertz R.E., Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 2006, 44:124-131.
19. Scott J.R., Hanage W.P., Lipsitch M., Millar E.V., Moulton L.H., Hinds J., et al. Pneumococcal sequence type replacement among American Indian children: a comparison of pre- and routine-PCV7 eras. Vaccine 2012, 30:2376-2381.
20. Wroe P.C., Lee G.M., Finkelstein J.A., Pelton S.I., Hanage W.P., Lipsitch M., et al. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J 2012, 31:249-254.
21. Yildirim I., Hanage W.P., Lipsitch M., Shea K.M., Stevenson A., Finkelstein J., et al. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 2010, 29:283-288.
22. Zuccotti G., Mameli C., Daprai L., Garlaschi M.L., Dilillo D., Bedogni G., et al. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Vaccine 2014, 32:527-534.